Indivior PLC Files Q1 2025 10-Q
Ticker: INDV · Form: 10-Q · Filed: May 1, 2025 · CIK: 1625297
| Field | Detail |
|---|---|
| Company | Indivior PLC (INDV) |
| Form Type | 10-Q |
| Filed Date | May 1, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, financials
TL;DR
Indivior PLC's Q1 2025 10-Q is in. Check financials.
AI Summary
Indivior PLC filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter of 2025. Key financial data and disclosures relevant to investors are presented.
Why It Matters
This filing provides investors with the latest financial performance and disclosures for Indivior PLC, crucial for understanding the company's current health and future prospects.
Risk Assessment
Risk Level: medium — The filing is a standard quarterly report, but the nature of pharmaceutical business and potential litigation can introduce inherent risks.
Key Players & Entities
- INDIVIOR PLC (company) — Filer
- 20250331 (date) — Reporting Period End Date
- 20250501 (date) — Filing Date
- 001-37835 (other) — SEC File Number
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 1, 2025.
What is the company's Central Index Key (CIK)?
The company's Central Index Key (CIK) is 0001625297.
What is Indivior PLC's fiscal year end?
Indivior PLC's fiscal year ends on December 31.
What is the business address listed for Indivior PLC?
The business address listed is 234 BATH ROAD, SLOUGH, BERKSHIRE, SL1 4EE.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 1, 2025 regarding INDIVIOR PLC (INDV).